Gene: FNDC4
Official Full Name: fibronectin type III domain containing 4provided by HGNC
Gene Summary: Involved in response to transforming growth factor beta. Predicted to be located in endoplasmic reticulum; extracellular space; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17561 | FNDC4 Knockout cell line (HCT 116) | Human | FNDC4 | 1:2~1:4 | Negative | Online Inquiry |
KO17562 | FNDC4 Knockout cell line (HEK293) | Human | FNDC4 | 1:3~1:6 | Negative | Online Inquiry |
KO17563 | FNDC4 Knockout cell line (A549) | Human | FNDC4 | 1:3~1:4 | Negative | Online Inquiry |
FNDC4 Gene Knockout Cell Lines are genetically modified cell lines in which the FNDC4 gene has been selectively disrupted. FNDC4, or Fibronectin Type III Domain-Containing Protein 4, is implicated in a variety of biological processes, including metabolic regulation and cellular signaling. By utilizing these knockout cell lines, researchers can effectively study the role of FNDC4 in various cellular pathways, particularly its involvement in energy metabolism and inflammation response mechanisms.
The primary function of FNDC4 Gene Knockout Cell Lines lies in their ability to provide a controlled environment for observing the consequences of FNDC4 absence. The mechanisms at play involve assessing changes in gene expression, protein interactions, and cellular behavior in the altered genetic context. This allows for a deeper understanding of FNDC4’s physiological roles and its involvement in disease states, particularly those related to obesity and metabolic syndrome.
In scientific research and clinical settings, FNDC4 Gene Knockout Cell Lines serve as invaluable tools for elucidating the pathophysiology of disorders linked to FNDC4 dysfunction. They can be utilized for drug screening, biomarker discovery, and to validate potential therapeutic targets. Their applications span molecular biology, pharmacology, and even translational medicine, marking them as essential resources for advancing biomedical knowledge.
Compared to alternative models, such as wild-type cell lines, FNDC4 knockout options offer direct insights into the gene's functional consequences, enabling more precise mechanistic studies. Additionally, the reproducibility and reliability of these engineered cell lines ensure consistent results, reducing variability often associated with primary cell cultures.
This product is particularly valuable for researchers and clinicians dedicated to understanding metabolic diseases and seeking new avenues for therapeutic interventions. Its capacity to elucidate the physiological roles of FNDC4 positions it as a critical component in the toolkit of modern biological research.
At [Your Company Name], we specialize in providing high-quality, genetically modified cell lines backed by extensive expertise in genetic engineering and molecular biology. Our commitment to innovation ensures we offer reliable and scientifically robust products that empower researchers in their quest for knowledge and advancement in healthcare.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.